Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts

BACKGROUND: The combination of EGFR tyrosine kinase inhibitors (TKIs) and chemotherapy is thought to increase treatment efficacy in non‐small‐cell lung cancer (NSCLC). This study investigated the efficacy and potential mechanisms of different combined modes of icotinib plus pemetrexed in EGFR‐mutant...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Cui, Jiadong, Zhang, Yan, Su, Di, Li, Tao, Li, Yu
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2018
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119608/
https://ncbi.nlm.nih.gov/pubmed/30047610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12818
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items